Fast multiple sclerosis progression in North Africans: Both genetics and environment matter

Youssef Sidhom1, Elisabeth Maillart2, Sophie Tezenas du Montcel2

  • 1From the Department of Neurology (Y.S., E.M., C.L., C.P.) and Biostatistics Unit (S.T.d.M.), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, France; Department of Neurology (Y.S., I.K., R.G.), UR12SP21, Razi Hospital; Faculty of Medicine of Tunis (Y.S., I.K., R.G.), University Tunis Elmanar, Tunisia; UMR_S1136 (S.T.d.M.) and UMR_S 1127 (C.L.), UPMC Univ Paris 06, Sorbonne Universités; and INSERM UMR_S 1136 (S.T.d.M.), Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. Youssef.sidhom@gmail.com.

Neurology
|February 26, 2017
PubMed
Summary

Multiple sclerosis (MS) progresses faster in North Africans (NAs), especially the second generation living in France. This indicates a distinct disease severity in this population group.